Reveromycin AAlternative Names: RM A
Latest Information Update: 27 Nov 2007
At a glance
- Originator Snow Brand Milk Products
- Class Cytostatic antibiotics; Pyrans; Spiro compounds
- Mechanism of Action Epidermal growth factor inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 14 Dec 2001 No-Development-Reported for Cancer in Japan (unspecified route)